Miahelsa HoldingsMiahelsa Holdings Corporation7129東証スタンダード小売業FY ending Mar 2026, consolidated, J-GAAP
About 29% of Miahelsa Holdings's sales come from Medicine business, with Childcare support business and Nurturing business making up much of the rest.
Out of every ¥100 of sales, about ¥2 is left as operating profit.
Revenue changed +2.1% from the prior year, operating profit +106.8%.
Revenue +2.1% · profit +106.8%, calculated from disclosed figures.
Operating leverage: 50.20× (profit growth ÷ revenue growth)
FY ending Mar 2023 → FY ending Mar 2024
FY ending Mar 2023 → FY ending Mar 2024
※ Segment revenues include inter-segment sales and are scaled to consolidated revenue
For every ¥100 Miahelsa Holdings sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
Revenue by business segment, and the profit each one keeps.
※ Segment figures include inter-segment sales and do not sum to the company total
EDINET (FSA Japan)
有価証券報告書－第5期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第4期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第3期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第2期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第1期(令和3年10月1日－令和4年3月31日)
Extracted from XBRL: 46 / Derived from other figures: 2
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.